Executive guts the company of any $ (near a million to Randy and Ian), goes onto raise at 3c per share:
This is the definition of lifestyling and a mistake that will last the remainder of Pointerra’s short life.
It’s all well and good to take a trim now but that is REACTIVE. The damage has already been done with coffers being near empty the duration of FY24.
Directors have strict obligations to act in a company’s best interests. Has the above remuneration been to the benefit of Pointerra, shareholders and growth?
I’ll leave that for you to decide.
On a side note, I cannot comprehend making reference to ARR in reports while the number itself remains MIA. RECURRING revenue must be extremely low. Circa $1- $3m at most (licence renewal only).
- Forums
- ASX - By Stock
- 3DP
- Presentations/Webinars/Podcasts/Media
Presentations/Webinars/Podcasts/Media, page-1725
-
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 3DP (ASX) to my watchlist
|
|||||
Last
4.7¢ |
Change
0.004(9.30%) |
Mkt cap ! $37.83M |
Open | High | Low | Value | Volume |
4.5¢ | 4.7¢ | 4.4¢ | $62.55K | 1.367M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22448 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 680345 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 22448 | 0.046 |
1 | 88547 | 0.045 |
1 | 11120 | 0.044 |
3 | 151395 | 0.043 |
2 | 455557 | 0.042 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 680345 | 5 |
0.048 | 653802 | 6 |
0.049 | 1080641 | 2 |
0.050 | 514085 | 6 |
0.051 | 92000 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
3DP (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online